drugset / Trial / NCT00810368

Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)

NCT00810368 ↗

Phase 2 Completed 33 enrolled Georgetown University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to perform a randomized double-blind, placebo-controlled, 12 week study of the effects of carnosine on cognitive, psychometric, autonomic, and muscle strength outcomes in 100 GWI subjects.

Timeline

Start
2008-08
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carnosine Peptide 1500 mg Oral

Indications